Finding Better Ways to Reduce Serious Drug Side Effects
Two UCSF School of Pharmacy faculty members, whose research and clinical practice have focused on the identification and minimization of side effects, have pinpointed routes for improvement.
University of California San Francisco
Give to UCSFTwo UCSF School of Pharmacy faculty members, whose research and clinical practice have focused on the identification and minimization of side effects, have pinpointed routes for improvement.
UCSF neuroscientists answered questions about a molecule that reverses severe memory and learning impairments in mice with traumatic brain injury.
In a new collaboration, ShangPharma Innovation, Inc. is providing funding and other support to scientists at UC San Francisco to accelerate the development of promising life science inventions.
UCSF scientists used an experimental drug to completely reverse severe learning and memory impairments caused by traumatic brain injury in mice.
Stephen L. Hauser will receive the 2017 Taubman Prize for Excellence in Translational Medical Research for his paradigm-changing discoveries that paved the way for a highly effective drug for the treatment of multiple sclerosis.
UCSF biochemist Charles Craik and pulmonologist Dean Sheppard have been elected to the American Academy of Arts and Sciences.
Researchers at UCSF and elsewhere are turning to virtual experiments for the initial steps of drug development.
UCSF researchers have used data-mining computational tools to identify a treatment for hepatocellular carcinoma, a cancer associated with underlying liver disease and cirrhosis that often only becomes symptomatic when it is very advanced.
A newly approved drug that is the first to reflect the current scientific understanding of multiple sclerosis is holding new hope for the hundreds of thousands Americans living with the disease. It also highlights the importance of clinician scientists like UCSF’s Stephen Hauser who are working to transform research into cures for patients.